ReviewTherapeutics and clinical risk management2015

Pharmacologic rationale underlying the therapeutic effects of tiotropium/olodaterol in COPD.

Girolamo Pelaia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.